Annarosaria De Chiara Selected Research

Annarosaria De Chiara Research Topics

Disease

13	Neoplasms (Cancer) 09/2021 - 05/2003
5	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 05/2003
3	Chondrosarcoma 01/2020 - 01/2011
3	Hemangiosarcoma (Angiosarcoma) 01/2017 - 09/2013
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2021 - 07/2012
2	Disease Progression 06/2021 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2006
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2012 - 10/2009
2	Thymus Neoplasms (Thymus Neoplasm) 01/2009 - 03/2002
1	COVID-19 06/2021
1	Severe Acute Respiratory Syndrome 06/2021
1	Infections 06/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Chordoma 11/2019
1	Soft Tissue Neoplasms 07/2017
1	Hemangiopericytoma 07/2017
1	Solitary Fibrous Tumors 07/2017
1	Osteosarcoma (Osteogenic Sarcoma) 08/2016
1	Hodgkin Disease (Hodgkin's Disease) 07/2014
1	Carcinogenesis 03/2013
1	Kaposi Sarcoma (Kaposi's Sarcoma) 08/2012
1	Rheumatoid Arthritis 08/2012
1	Breast Neoplasms (Breast Cancer) 08/2012
1	Leukemia 07/2012
1	T-Cell Lymphoma (Lymphoma, T Cell) 07/2012
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 07/2012
1	Lymphoma (Lymphomas) 07/2012
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2012
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2006
1	Thymoma (Thymic Carcinoma) 03/2002
1	Pure Red-Cell Aplasia 03/2002

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2017
3	Rituximab (Mabthera)FDA Link 06/2021 - 10/2009
3	AntibodiesIBA 06/2021 - 01/2017
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
2	Pharmaceutical PreparationsIBA 09/2021 - 01/2018
2	Biological ProductsIBA 01/2018 - 07/2017
2	VimentinIBA 10/2017 - 01/2006
2	Proteins (Proteins, Gene)FDA Link 10/2017 - 03/2013
2	Peptides (Polypeptides)IBA 08/2016 - 01/2011
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2016 - 01/2011
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2009 - 05/2003
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2009 - 03/2002
1	Antisense RNA (Anti-Sense RNA)IBA 09/2021
1	Long Noncoding RNAIBA 09/2021
1	Viral RNAIBA 06/2021
1	RNA (Ribonucleic Acid)IBA 06/2021
1	Immunoglobulin G (IgG)IBA 06/2021
1	Immunoglobulin M (IgM)IBA 06/2021
1	Monoclonal AntibodiesIBA 01/2021
1	NivolumabIBA 01/2021
1	Purinergic Receptors (Receptors, Purine)IBA 01/2021
1	pembrolizumabIBA 01/2021
1	Collagen Type IV (Type IV Collagen)IBA 01/2018
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2018
1	Claudin-1IBA 01/2018
1	Hyaluronic Acid (Hyaluronan)IBA 10/2017
1	cadherin 5IBA 10/2017
1	B7-H1 AntigenIBA 01/2017
1	Cyclic PeptidesIBA 08/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Vinblastine (Vinblastine Sulfate)FDA Link 07/2014
1	Bleomycin (Blenoxane)FDA LinkGeneric 07/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2014
1	Dacarbazine (DIC)FDA LinkGeneric 07/2014
1	Angiogenesis InhibitorsIBA 04/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2012
1	Cyclin D1IBA 07/2012
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2012
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2011
1	matrigelIBA 01/2011
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2009
1	Gemcitabine FDA Link 10/2009
1	Imatinib Mesylate (Gleevec)FDA Link 01/2006
1	Messenger RNA (mRNA)IBA 05/2003
1	Octreotide (Sandostatin)FDA LinkGeneric 03/2002
1	IndiumIBA 03/2002
1	Prednisone (Sone)FDA LinkGeneric 03/2002

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2006
4	Drug Therapy (Chemotherapy) 01/2021 - 07/2012
4	Radiotherapy 01/2021 - 09/2013
2	Immunotherapy 01/2021 - 01/2017
1	Precision Medicine 01/2018
1	Prostatectomy (Retropubic Prostatectomy) 07/2017
1	Salvage Therapy 10/2009